594 research outputs found
Recombinant AAV Vectors for Enhanced Expression of Authentic IgG
Adeno-associated virus (AAV) has become a vector of choice for the treatment of a variety of genetic diseases that require safe and long-term delivery of a missing protein. Muscle-directed gene transfer for delivery of protective antibodies against AIDS viruses and other pathogens has been used experimentally in mice and monkeys. Here we examined a number of variations to AAV vector design for the ability to produce authentic immunoglobulin G (IgG) molecules. Expression of rhesus IgG from a single single-stranded AAV (ssAAV) vector (one vector approach) was compared to expression from two self-complementary AAV (scAAV) vectors, one for heavy chain and one for light chain (two vector approach). Both the one vector and the two vector approaches yielded considerable levels of expressed full-length IgG. A number of modifications to the ssAAV expression system were then examined for their ability to increase the efficiency of IgG expression. Inclusion of a furin cleavage sequence with a linker peptide just upstream of the 2A self-cleaving sequence from foot-and-mouth disease virus (F2A) increased IgG expression approximately 2 fold. Inclusion of these sequences also helped to ensure a proper sequence at the C-terminal end of the heavy chain. Inclusion of the post-transcriptional regulatory element from woodchuck hepatitis virus (WPRE) further increased IgG expression 1.5-2.0 fold. IgG1 versions of the two rhesus IgGs that were examined consistently expressed better than the IgG2 forms. In contrast to what has been reported for AAV2-mediated expression of other proteins, introduction of capsid mutations Y445F and Y731F did not increase ssAAV1-mediated expression of IgG as determined by transduction experiments in cell culture. Our findings provide a rational basis for AAV vector design for expression of authentic IgG
Recommended from our members
Liver-Directed but Not Muscle-Directed AAV-Antibody Gene Transfer Limits Humoral Immune Responses in Rhesus Monkeys
A number of publications have described the use of adeno-associated virus (AAV) for the delivery of anti-HIV and anti-simian immunodeficiency virus (SIV) monoclonal antibodies (mAbs) to rhesus monkeys. Anti-drug antibodies (ADAs) have been frequently observed, and long-term AAV-mediated delivery has been inconsistent. Here, we investigated different AAV vector strategies and delivery schemes to rhesus monkeys using the rhesus monkey mAb 4L6. We compared 4L6 immunoglobulin G1 (IgG1) delivery using the AAV1 versus the AAV8 serotype with a cytomegalovirus (CMV) promoter and the use of a muscle-specific versus a liver-specific promoter. Long-term expression levels of 4L6 IgG1 following AAV8-mediated gene transfer were comparable to those following AAV1-mediated gene transfer. AAV1-mediated gene transfer, using a muscle-specific promoter, showed robust ADAs and transiently low 4L6 IgG1 levels that ultimately declined to below detectable levels. Intravenous AAV8-mediated gene transfer, using a liver-specific promoter, also resulted in low levels of delivered 4L6 IgG1, but those low levels were maintained in the absence of any detectable ADAs. Booster injections using AAV1-CMV allowed for increased 4L6 IgG1 serum levels in animals that were primed with AAV8 but not with AAV1. Our results suggest that liver-directed expression may help to limit ADAs and that re-administration of AAV of a different serotype can result in successful long-term delivery of an immunogenic antibody
Response of micro- and macrovascular endothelial cells to starch-based fiber meshes for bone tissue engineering
The establishment of a functional vasculature is as yet an unrealized milestone in bone reconstruction therapy. For this study, fibermesh
scaffolds obtained from a blend of starch and poly(caprolactone) (SPCL), that have previously been shown to be an excellent
material for the proliferation and differentiation of bone marrow cells and thereby represent great potential as constructs for bone
regeneration, were examined for endothelial cell (EC) compatibility. To be successfully applied in vivo, this tissue engineered construct
should also be able to support the growth of ECs in order to facilitate vascularization and therefore assure the viability of the construct
upon implantation. The main goal of this study was to examine the interactions between ECs and SPCL fiber meshes. Primary cultures of
HUVEC cells were selected as a model of macrovascular cells and the cell line HPMEC-ST1.6R as a model for microvascular ECs.
Both macro- and microvascular ECs adhered to SPCL fiber-mesh scaffolds and grew to cover much of the available surface area of the
scaffold. In addition, ECs growing on the SPCL fibers exhibited a typical morphology, maintained important functional properties, such
as the expression of the intercellular junction proteins, PECAM-1 and VE-cadherin, the expression of the most typical endothelial
marker vWF and sensitivity to pro-inflammatory stimuli, as shown by induction of the expression of cell adhesion molecules (CAMs) by
lipopolysaccharide (LPS). These data indicate that ECs growing on SPCL fiber-mesh scaffolds maintain a normal expression of ECspecific
genes/proteins, indicating a cell compatibility and potential suitability of these scaffolds for the vascularization process in bone
tissue engineering in vivo
AAV-Delivered Antibody Mediates Significant Protective Effects against SIVmac239 Challenge in the Absence of Neutralizing Activity
Long-term delivery of potent broadly-neutralizing antibodies is a promising approach for the prevention of HIV-1 infection. We used AAV vector intramuscularly to deliver anti-SIV monoclonal antibodies (mAbs) in IgG1 form to rhesus monkeys. Persisting levels of delivered mAb as high as 270 mug/ml were achieved. However, host antibody responses to the delivered antibody were observed in 9 of the 12 monkeys and these appeared to limit the concentration of delivered antibody that could be achieved. This is reflected in the wide range of delivered mAb concentrations that were achieved: 1-270 mug/ml. Following repeated, marginal dose, intravenous challenge with the difficult-to-neutralize SIVmac239, the six monkeys in the AAV-5L7 IgG1 mAb group showed clear protective effects despite the absence of detectable neutralizing activity against the challenge virus. The protective effects included: lowering of viral load at peak height; lowering of viral load at set point; delay in the time to peak viral load from the time of the infectious virus exposure. All of these effects were statistically significant. In addition, the monkey with the highest level of delivered 5L7 mAb completely resisted six successive SIVmac239 i.v. challenges, including a final challenge with a dose of 10 i.v. infectious units. Our results demonstrate the continued promise of this approach for the prevention of HIV-1 infection in people. However, the problem of anti-antibody responses will need to be understood and overcome for the promise of this approach to be effectively realized
Surface-modified 3D starch-based scaffold for improved endothelialization for bone tissue engineering
Providing adequate vascularization is one of the main hurdles to the widespread clinical application of
bone tissue engineering approaches. Due to their unique role in blood vessel formation, endothelial
cells (EC) play a key role in the establishment of successful vascularization strategies. However,
currently available polymeric materials do not generally support EC growth without coating with
adhesive proteins. In this work we present argon plasma treatment as a suitable method to render the
surface of a 3D starch-based scaffold compatible for ECs, this way obviating the need for protein precoating.
To this end we studied the effect of plasma modification on surface properties, protein
adsorption and ultimately on several aspects regarding EC behaviour. Characterization of surface
properties revealed increased surface roughness and change in topography, while at the chemical level
a higher oxygen content was demonstrated. The increased surface roughness of the material, together
with the changed surface chemistry modulated protein adsorption as indicated by the different
adsorption profile observed for vitronectin. In vitro studies showed that human umbilical vein ECs
(HUVECs) seeded on plasma-modified scaffolds adhered, remained viable, proliferated, and
maintained the typical cobblestone morphology, as observed for positive controls (scaffold pre-coated
with adhesive proteins). Furthermore, genotypic expression of endothelial markers was maintained and
neighbouring cells expressed PECAM-1 at the single-cell-level. These results indicate that Ar plasma
modification is an effective methodology with potential to be incorporated in biomaterial strategies to
promote the formation of vascularized engineered bone
Endothelial cell colonization and angiogenic potential of combined nano- and micro-fibrous scaffolds for bone tissue engineering
Presently the majority of tissue engineering approaches aimed at regenerating bone relies only on postimplantation
vascularization. Strategies that include seeding endothelial cells (ECs) on biomaterials
and promoting their adhesion, migration and functionality might be a solution for the formation of
vascularized bone. Nano/micro-fiber-combined scaffolds have an innovative structure, inspired by
extracellular matrix (ECM) that combines a nano-network, aimed to promote cell adhesion, with
a micro-fiber mesh that provides the mechanical support. In this work we addressed the influence of
this nano-network on growth pattern, morphology, inflammatory expression profile, expression of
structural proteins, homotypic interactions and angiogenic potential of human EC cultured on a scaffold
made of a blend of starch and poly(caprolactone). The nano-network allowed cells to span between
individual micro-fibers and influenced cell morphology. Furthermore, on nano-fibers as well as on
micro-fibers ECs maintained the physiological expression pattern of the structural protein vimentin and
PECAM-1 between adjacent cells. In addition, ECs growing on the nano/micro-fiber-combined scaffold
were sensitive to pro-inflammatory stimulus. Under pro-angiogenic conditions in vitro, the ECM-like
nano-network provided the structural and organizational stability for ECs’ migration and organization
into capillary-like structures. The architecture of nano/micro-fiber-combined scaffolds elicited and
guided the 3D distribution of ECs without compromising the structural requirements for bone
regeneration.M.I. Santos would like to acknowledge the Portuguese Foundation for Science and Technology (FCT) for her PhD scholarship (SFRH/BD/13428/2003). This work was partially supported by FCT through funds from POCTI and/or FEDER programs and by the European Union funded STREP Project HIPPOCRATES (NMP3-CT-2003-505758). This work was carried out under the scope of the European NoE EXPERTISSUES (NMP3-CT-2004-500283)
Economic Implications of a Delayed Uniform Planting Date for Cotton Production in the Texas Rolling Plains.
40 p
Demonstration of entanglement-by-measurement of solid state qubits
Projective measurements are a powerful tool for manipulating quantum states.
In particular, a set of qubits can be entangled by measurement of a joint
property such as qubit parity. These joint measurements do not require a direct
interaction between qubits and therefore provide a unique resource for quantum
information processing with well-isolated qubits. Numerous schemes for
entanglement-by-measurement of solid-state qubits have been proposed, but the
demanding experimental requirements have so far hindered implementations. Here
we realize a two-qubit parity measurement on nuclear spins in diamond by
exploiting the electron spin of a nitrogen-vacancy center as readout ancilla.
The measurement enables us to project the initially uncorrelated nuclear spins
into maximally entangled states. By combining this entanglement with
high-fidelity single-shot readout we demonstrate the first violation of Bells
inequality with solid-state spins. These results open the door to a new class
of experiments in which projective measurements are used to create, protect and
manipulate entanglement between solid-state qubits.Comment: 6 pages, 4 figure
Development of the first marmoset-specific DNA microarray (EUMAMA): a new genetic tool for large-scale expression profiling in a non-human primate
Contains fulltext :
34911.pdf (publisher's version ) (Open Access)BACKGROUND: The common marmoset monkey (Callithrix jacchus), a small non-endangered New World primate native to eastern Brazil, is becoming increasingly used as a non-human primate model in biomedical research, drug development and safety assessment. In contrast to the growing interest for the marmoset as an animal model, the molecular tools for genetic analysis are extremely limited. RESULTS: Here we report the development of the first marmoset-specific oligonucleotide microarray (EUMAMA) containing probe sets targeting 1541 different marmoset transcripts expressed in hippocampus. These 1541 transcripts represent a wide variety of different functional gene classes. Hybridisation of the marmoset microarray with labelled RNA from hippocampus, cortex and a panel of 7 different peripheral tissues resulted in high detection rates of 85% in the neuronal tissues and on average 70% in the non-neuronal tissues. The expression profiles of the 2 neuronal tissues, hippocampus and cortex, were highly similar, as indicated by a correlation coefficient of 0.96. Several transcripts with a tissue-specific pattern of expression were identified. Besides the marmoset microarray we have generated 3215 ESTs derived from marmoset hippocampus, which have been annotated and submitted to GenBank [GenBank: EF214838-EF215447, EH380242-EH382846]. CONCLUSION: We have generated the first marmoset-specific DNA microarray and demonstrated its use to characterise large-scale gene expression profiles of hippocampus but also of other neuronal and non-neuronal tissues. In addition, we have generated a large collection of ESTs of marmoset origin, which are now available in the public domain. These new tools will facilitate molecular genetic research into this non-human primate animal model
- …